Armodafinil Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg, 150 mg, 200 mg
Reference Brands: Nuvigil (USA), Modavigil(EU)
Category:
Neurology
Armodafinil is a wakefulness-promoting agent used to treat excessive sleepiness caused by narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD). It is the R-enantiomer of modafinil, providing a longer, more sustained effect on alertness. Available as oral tablets in various strengths (50 mg, 150 mg, 200 mg, 250 mg), Armodafinil helps patients stay awake and improve daytime functioning.
Armodafinil is available in Tablets
and strengths such as 50 mg, 150 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Armodafinil is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Armodafinil can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Armodafinil is a wakefulness-promoting medication used to manage excessive daytime sleepiness associated with sleep-wake disorders such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is the R-enantiomer of modafinil and is designed to provide longer-lasting alertness and improved daytime functioning in patients who struggle to stay awake. The medication is taken orally, usually in tablet form, and is widely prescribed in sleep medicine and neurology practice.
Armodafinil works by influencing certain neurotransmitters in the brain that regulate the sleep-wake cycle and promote alertness. Compared with some traditional stimulants, it is considered to have a more targeted effect on wakefulness with a relatively controlled stimulation profile. This makes it a useful option for patients who require sustained wakefulness during working hours or daily activities.
Today, Armodafinil is available in several pharmaceutical markets under different brand names and is commonly categorized under neurology and sleep disorder treatments in global pharmaceutical listings and medical platforms.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing